These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12734680)

  • 1. Doxorubicin activity is enhanced by hyperthermia in a model of ex vivo vascular perfusion of human colon carcinoma.
    Pilati P; Mocellin S; Rossi CR; Scalerta R; Alaggio R; Giacomelli L; Geroni C; Nitti D; Lise M
    World J Surg; 2003 Jun; 27(6):640-6. PubMed ID: 12734680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced delivery and antitumor activity of doxorubicin using long-circulating thermosensitive liposomes containing amphipathic polyethylene glycol in combination with local hyperthermia.
    Unezaki S; Maruyama K; Takahashi N; Koyama M; Yuda T; Suginaka A; Iwatsuru M
    Pharm Res; 1994 Aug; 11(8):1180-5. PubMed ID: 7971721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperthermia-enhanced tumor accumulation and antitumor efficacy of a doxorubicin-conjugate with a novel macromolecular carrier system in mice with non-small cell lung cancer.
    Oyama T; Kawamura M; Abiko T; Izumi Y; Watanabe M; Kumazawa E; Kuga H; Shiose Y; Kobayashi K
    Oncol Rep; 2007 Mar; 17(3):653-9. PubMed ID: 17273747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced delivery of doxorubicin to tumor by long-circulating thermosensitive liposomes and local hyperthermia.
    Maruyama K; Unezaki S; Takahashi N; Iwatsuru M
    Biochim Biophys Acta; 1993 Jul; 1149(2):209-16. PubMed ID: 8323940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacokinetics of tetrahydropyranyl-doxorubicin and doxorubicin in rat isolated lung.
    Dumas M; Dubuet A; D'Athis P; Camus P; Escousse A
    J Pharm Pharmacol; 1992 Jan; 44(1):58-60. PubMed ID: 1350631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of proliferation in HER2 status predicted response to doxorubicin.
    Campiglio M; Somenzi G; Olgiati C; Beretta G; Balsari A; Zaffaroni N; Valagussa P; Ménard S
    Int J Cancer; 2003 Jul; 105(4):568-73. PubMed ID: 12712452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy and microSPECT/CT imaging of 188Re-DXR-liposome in a C26 murine colon carcinoma solid tumor model.
    Chang YJ; Chang CH; Yu CY; Chang TJ; Chen LC; Chen MH; Lee TW; Ting G
    Nucl Med Biol; 2010 Jan; 37(1):95-104. PubMed ID: 20122674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthermic isolated perfusion with low-dose tumor necrosis factor alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcomas.
    Rossi CR; Mocellin S; Pilati P; Foletto M; Campana L; Quintieri L; De Salvo GL; Lise M
    Ann Surg Oncol; 2005 May; 12(5):398-405. PubMed ID: 15915374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topoisomerase II alpha expression in normal, inflammatory, and neoplastic conditions of the gastric and colonic mucosa.
    Fogt F; Nikulasson ST; Holden JA; Alder SA; Hallgrimsson J; Jessup MJ; O'Brien MJ; Lavin PT; Goldman H
    Mod Pathol; 1997 Apr; 10(4):296-302. PubMed ID: 9110290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, biodistribution, and pharmacokinetics of CD22-targeted pegylated liposomal doxorubicin in a B-cell non-Hodgkin's lymphoma xenograft mouse model.
    Tuscano JM; Martin SM; Ma Y; Zamboni W; O'Donnell RT
    Clin Cancer Res; 2010 May; 16(10):2760-8. PubMed ID: 20460479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II-induced hypertension enhanced therapeutic efficacy of liposomal doxorubicin in tumor-bearing mice.
    Hattori Y; Ubukata H; Kawano K; Maitani Y
    Int J Pharm; 2011 Jan; 403(1-2):178-84. PubMed ID: 20934498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of two different delivery regimens of doxorubicin in isolated hyperthermic limb perfusion.
    Pfeiffer T; Krause U; Thome U; Skorzek M; Scheulen ME
    Eur J Surg Oncol; 1995 Oct; 21(5):551-4. PubMed ID: 7589605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of PK1 and doxorubicin in experimental colon tumor models with differing responses to PK1.
    Loadman PM; Bibby MC; Double JA; Al-Shakhaa WM; Duncan R
    Clin Cancer Res; 1999 Nov; 5(11):3682-8. PubMed ID: 10589787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of pharmacokinetic and antitumor activity of PEGylated liposomal doxorubicin by targeting with N-methylated cyclic RGD peptide in mice bearing C-26 colon carcinomas.
    Amin M; Badiee A; Jaafari MR
    Int J Pharm; 2013 Dec; 458(2):324-33. PubMed ID: 24148663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution characteristics of carboxymethylpullulan-peptide-doxorubicin conjugates in tumor-bearing rats: different sequence of peptide spacers and doxorubicin contents.
    Nogusa H; Yamamoto K; Yano T; Kajiki M; Hamana H; Okuno S
    Biol Pharm Bull; 2000 May; 23(5):621-6. PubMed ID: 10823676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.
    Lopes de Menezes DE; Pilarski LM; Allen TM
    Cancer Res; 1998 Aug; 58(15):3320-30. PubMed ID: 9699662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, micro-SPECT/CT imaging and therapeutic efficacy of (188)Re-DXR-liposome in C26 colon carcinoma ascites mice model.
    Chen LC; Chang CH; Yu CY; Chang YJ; Wu YH; Lee WC; Yeh CH; Lee TW; Ting G
    Nucl Med Biol; 2008 Nov; 35(8):883-93. PubMed ID: 19026950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue distribution, antitumour activity and in vivo apoptosis induction by MEN10755 in nude mice.
    Gonzalez-Paz O; Polizzi D; De Cesare M; Zunino F; Bigioni M; Maggi CA; Manzini S; Pratesi G
    Eur J Cancer; 2001 Feb; 37(3):431-7. PubMed ID: 11239767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insight into hyperthermic intraperitoneal chemotherapy: induction of oxidative stress dramatically enhanced tumor killing in in vitro and in vivo models.
    Lehmann K; Rickenbacher A; Jang JH; Oberkofler CE; Vonlanthen R; von Boehmer L; Humar B; Graf R; Gertsch P; Clavien PA
    Ann Surg; 2012 Nov; 256(5):730-7; discussion 737-8. PubMed ID: 23095616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of repetitive administration of Doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumor model.
    Arnold RD; Mager DE; Slack JE; Straubinger RM
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8856-65. PubMed ID: 16361575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.